PCMC vs PBSV: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

PBSV has stronger fundamentals based on our AI analysis.

PCMC
PUBLIC CO MANAGEMENT CORP
STRONG SELL
95%
Confidence
VS
PBSV
Pharma-Bio Serv, Inc.
SELL
78%
Confidence

PCMC vs PBSV Fundamental Comparison

Metric PCMC PBSV
Revenue N/A $2.3M
Net Income $-17,023.0 $32,860.0
Net Margin N/A 1.4%
ROE N/A 0.3%
ROA -6.6% 0.2%
Current Ratio 0.53x 4.03x
Debt/Equity N/A 0.00x
EPS $0.00 $0.00

Green = Better metric | Red = Weaker metric

View Full PCMC Analysis →
View Full PBSV Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

PCMC vs AAPL PBSV vs MSFT PCMC vs GOOGL PBSV vs AMZN

PCMC vs PBSV: Frequently Asked Questions

Is PCMC or PBSV a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), PBSV has stronger fundamentals. PCMC is rated STRONG SELL (95% confidence) while PBSV is rated SELL (78% confidence). This is not investment advice.

How does PCMC compare to PBSV fundamentally?

PUBLIC CO MANAGEMENT CORP has ROE of N/A vs Pharma-Bio Serv, Inc.'s 0.3%. Net margins are N/A vs 1.4% respectively.

Which stock pays higher dividends, PCMC or PBSV?

PCMC has a dividend yield of N/A or no dividend while PBSV has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in PCMC or PBSV for long term?

For long-term investing, consider that PCMC has STRONG SELL rating with 95% confidence, while PBSV has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about PCMC vs PBSV?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PCMC vs PBSV, the AI consensus favors PBSV based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.